Thus, considering our previous study reporting the impact of the iNOS/NO system on CRC immune escape, tissue damage, and response to therapy (29), we sought to assess the NOS2/ARG1 Axis in different stages of CRC. This evidence concerns the gene NOS2 and colorectal carcinoma.